TECH
Bio-Techne Corporation
Biotechnology · Healthcare · United States
72.71
close · 2026-10-29
value
30
cheaper than peers30
quality
78
stronger fundamentals78
ranked against
Biotechnology (commercial)
value
quality
161 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 9.29× | 59 |
| price to book | 5.38× | 34 |
| EV to EBITDA | 31.07× | 34 |
| forward P/E | 31.46× | 24 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 25.2% | 89 |
| return on equity | 5.3% | 83 |
| debt to equity | 13.9% | 56 |
| revenue growth | -1.5% | 34 |
4 of 4 measures available
Facts
| market cap | $11B |
| free cash flow | $299.8M |
| employees | 3,100 |
| first trade | 1989-02-09 |
| next earnings | 2026-08-12 |
| fundamentals updated | 2026-08-12 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 0.46 | 1.05 | 1.76 | 1.66 |
| free cash flow | $256.6M | $236.1M | $216.1M | $280.4M |
| net income | $73.4M | $168.1M | $285.3M | $272.1M |
| revenue | $1.22B | $1.16B | $1.14B | $1.11B |
| unusual items | -$140.7M | -$41.8M | $56.1M | $14.6M |